Guardian Pharmacy Services (GRDN) Depreciation & Amortization (CF) (2023 - 2026)

Guardian Pharmacy Services has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $6.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 13.46% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.0 million (up 13.58% YoY) and the FY2025 annual result came in at $22.3 million, up 12.96% from the prior year.
• Depreciation & Amortization (CF) climbed to $6.0 million in Q1 2026 per GRDN's latest filing, from $5.7 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $6.0 million in Q1 2026 and troughed at $4.7 million in Q4 2023.
• A 4-year average of $5.3 million and a median of $5.2 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) climbed 9.31% in 2024, then gained 16.9% in 2025.
• Over 4 years, Depreciation & Amortization (CF) stood at $4.7 million in 2023, then gained by 9.31% to $5.2 million in 2024, then climbed by 11.41% to $5.7 million in 2025, then climbed by 4.09% to $6.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $6.0 million, $5.7 million, and $5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.